课题基金 / 基金详情

MOLECULAR GENETIC EVENTS IN LUNG CANCER

MOLECULAR GENETIC EVENTS IN LUNG CANCER
肺癌中的分子遗传事件
批准号:
3774600
负责人:
B E JOHNSON
金额:
$0.0万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:

项目摘要

项目成果

B E JOHNSON的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
A. The atrial natriuretic factor A receptor mRNA has been detected on small cell lung cancer cells by PCR analysis of cDNA from the cell lines and RNase protection assay. Binding studies with iodinated ANF showed saturable binding but the number of sites on the small cell lung cancer cell lines, NCI-H82, NCI-H660, NCI-H1284, were to low to accurately estimate. The cells respond to exogenously added atrial natriuretic factor with an increase in intracellular cGMP, similar to the normal receptors. Therefore, there appear to be functional ANF receptors on the surface of small cell lung cancer cells. B. The serum and urine calcitonin values of 86 different individuals were studied by radioimmunoassay which included 20 nonsmokers, 17 smokers, and 49 patients with small cell lung cancer. The urine values were the most different in these three groups of individuals (p is less than or equal to 0.00001). RNase protection assays (RPA) and RIAs of 16 tumor cell lines from these patients with small cell lung cancer showed five had elevated serum and/or urine calcitonin values but did not have ectopic calcitonin production in their tumor cell lines. Therefore, it appears that elevated calcitonin levels in patients with lung cancer can come from a source other than the tumor cells.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
IN VITRO DRUG TESTING FOR LIMITED SCLC AND PHASE I DRUG DEVELOPMENT
  • 批准号:
    3939554
  • 项目类别:
  • 资助金额:
    $0.0万
  • 财政年份:
    --
  • 负责人:
    B E JOHNSON
  • 依托单位:
MOLECULAR GENETIC EVENTS IN LUNG CANCER
  • 批准号:
    3838085
  • 项目类别:
  • 资助金额:
    $0.0万
  • 财政年份:
    --
  • 负责人:
    B E JOHNSON
  • 依托单位:
IN VITRO DRUG TESTING FOR LIMITED SCLC AND PHASE I DRUG DEVELOPMENT
  • 批准号:
    3853211
  • 项目类别:
  • 资助金额:
    $0.0万
  • 财政年份:
    --
  • 负责人:
    B E JOHNSON
  • 依托单位:
IN VITRO DRUG TESTING FOR LIMITED SCLC AND PHASE I DRUG DEVELOPMENT
  • 批准号:
    3916620
  • 项目类别:
  • 资助金额:
    $0.0万
  • 财政年份:
    --
  • 负责人:
    B E JOHNSON
  • 依托单位:
海外基金